Skip to main content
Carlo Bifulco, MD, Pathology, New Haven, CT, Providence Milwaukie Hospital

CarloBrunoBifulcoMD

Pathology • New Haven, CT

Hematopathology, Molecular Genetics, Anatomic Pathology

Physician

Join to view full profile

Dr. Bifulco is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bifulco's full profile

Already have an account?

  • Office

    20 York St
    Yale-New Haven Children's Hospital-Ep 2608
    New Haven, CT 06510
    Phone+1 203-785-3624
    Fax+1 203-785-7037
  • Is this information wrong?

Education & Training

  • Memorial Sloan Kettering Cancer Center Oncologic Pathology
    Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 1998 - 2000
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 1996 - 1997
  • Griffin Hospital
    Griffin HospitalInternship, Internal Medicine, 1995 - 1996
  • University of Milan Faculty of Medicine
    University of Milan Faculty of MedicineClass of 1994

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2008 - 2025
  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Molecular Genetic Pathology

Publications & Presentations

PubMed

Abstracts/Posters

  • Flotetuzumab (FLZ), an Investigational CD123 x CD3 Bispecific Dart¬ Protein-Induced Clustering of CD3+ T Cells and CD123+ AML Cells in Bone Marrow Biopsies Is Associat...
    Carlo B Bifulco, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • Blood Tests That Can Detect Cancer Are About to Hit the Market. But Experts Are Still Waiting to See if They Can Upend Deadly Disease
    Blood Tests That Can Detect Cancer Are About to Hit the Market. But Experts Are Still Waiting to See if They Can Upend Deadly DiseaseOctober 20th, 2021
  • Providence Molecular Genomics Lab Utilizes Illumina Technology to Offer Genomics for All
    Providence Molecular Genomics Lab Utilizes Illumina Technology to Offer Genomics for AllAugust 18th, 2021
  • Lunaphore Appoints Dr. Carlo Bifulco to Scientific Advisory Board
    Lunaphore Appoints Dr. Carlo Bifulco to Scientific Advisory BoardJune 17th, 2021
  • Join now to see all

Hospital Affiliations

Dr. Carlo Bifulco, Dr. Carlo Bifulco, MD, Dr. C Bifulco, Dr. Carlo Bruno Bifulco